Abstract | BACKGROUND/AIMS: MATERIAL AND METHODS: We retrospectively reviewed 111 ESCN in 86 patients treated by ESD between September 2007 and April 2013. There were four double cancers, with 107 ESD procedures analyzed. RESULTS: The en bloc resection rate was 99% (106/107). The R0 resection rate was 93% (99/107). Of 106 specimens resected en bloc, four specimens had a positive horizontal margin, two specimens had non-assessable horizontal margins and one specimen had non-assessable horizontal and vertical margins. One patient with a non-assessable horizontal margin developed local recurrence seven months later, treated by repeat ESD. Delayed bleeding occurred in two procedures (2%), and intra-procedural perforation occurred in four (4%). None required operative repair. Endoscopy trainees performed 33 of 107 (31%) ESD procedures. Post-ESD stenosis requiring dilation occurred following five procedures (5%). CONCLUSIONS:
Sodium hyaluronate for ESD of ESCN achieves a high R0 resection rate with a low rate of adverse events.
|
Authors | Chihiro Iwashita, Hirotsugu Sakamoto, Yoshimasa Miura, Satoshi Shinozaki, Yoshikazu Hayashi, Yuji Ino, Hiroyuki Osawa, Mio Tamba, Kohei Morita, Alan Kawarai Lefor, Hironori Yamamoto |
Journal | Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy
(Minim Invasive Ther Allied Technol)
Vol. 27
Issue 3
Pg. 171-176
(Jun 2018)
ISSN: 1365-2931 [Electronic] England |
PMID | 28749205
(Publication Type: Journal Article)
|
Chemical References |
- Solutions
- Hyaluronic Acid
|
Topics |
- Aged
- Carcinoma, Squamous Cell
(pathology, surgery)
- Dissection
- Endoscopic Mucosal Resection
(methods)
- Esophageal Mucosa
(pathology, surgery)
- Esophageal Neoplasms
(pathology, surgery)
- Esophagoscopy
- Female
- Humans
- Hyaluronic Acid
(administration & dosage)
- Male
- Middle Aged
- Retrospective Studies
- Solutions
(administration & dosage)
- Treatment Outcome
|